Jideytro

zidesamtinib · ZIDESAMTINIB 25 mg/1 · Tablet, Film Coated · Oral · Nuvalent, Inc.

NDC 85001-0101-01 · 1 BOTTLE in 1 CARTON / 30 TABLET, FILM COATED in 1 BOTTLE · NDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application: NDA220185
TE code: —
Approval date: Jul 22, 2026
Patents / exclusivity: 8 patents, 0 exclusivities

Type	Number / code	Expires
patent	12043626	Sep 30, 2042
patent	12630560	Sep 30, 2042
patent	12043626	Sep 30, 2042
patent	12630560	Sep 30, 2042
patent	11542278	May 5, 2041
patent	12054498	May 5, 2041
patent	12054498	May 5, 2041
patent	11542278	May 5, 2041

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of zidesamtinib (Tablet, Film Coated)

Labeler	Strength	First seen	Last seen
Patheon Inc.	ZIDESAMTINIB 100 mg/1	Jul 29, 2026	Sep 2, 2026
Patheon Inc.	ZIDESAMTINIB 25 mg/1	Jul 29, 2026	Sep 2, 2026
Nuvalent, Inc.	ZIDESAMTINIB 100 mg/1	Jul 31, 2026	Aug 28, 2026
Nuvalent, Inc.	ZIDESAMTINIB 25 mg/1	Jul 31, 2026	Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Jideytro — NDC 85001-0101-01," retrieved September 3, 2026, https://drugdashboards.com/drug/85001010101.

Free to cite with attribution — see how the data is put together.